Market study on competition in online payments

We are pleased to announce that our “Market Study on Competition in Online Payments” has been published by the European Commission. The study was caried out by a consortium comprising Lear, Capgemini and Verian, and led by Lear.

This study analyses the intensity of competition in the online payment sector in the EEA, with a focus on 14 countries.

Read more

Market study on the supply and repair of household appliance in Singapore

Lear has led a Consortium comprising Verian and Euromonitor, to carry out a market study on the supply and repair of household appliances, commissioned by the National Environmental Agency and the Competition and Consumer Commission of Singapore. The market study allowed the Consortium to reconstruct the value chains for the supply and repair of large and small household appliances, to discover the relevant factors considered by consumers when choosing whether to repair or replace their appliances, and to identify the key inputs required for repair.
Read more

Lear at the College of Europe Career Day

Lear is excited to participate in the College of Europe Career Day in Bruges on March 12, 2025.

This event is a great opportunity for students to explore career paths in economic consulting, antitrust, and regulation. We will be present throughout the day to meet students, answer questions, and share insights into career opportunities at Lear.

Read more

Lear recognized by GCR as one of the Top 20 Competition Economics Firms

We are proud to announce that Global Competition Review has once again recognised Lear as one of the top 20 competition economics consultancies worldwide in the GCR💯 ranking! Read more

Lear Competition Festival 2025 – Registration is open!

This edition will be truly special as we celebrate 20 years of the Lear Conference! Get ready for new partners, cutting-edge topics, distinguished international speakers, and unique opportunities for the international antitrust community.

WHAT TO EXPECT FROM LCF25? Read more

Workshop – Relazioni Pericolose: Acquisizioni e innovazione nel settore farmaceutico – Slides e Video

Si è recentemente concluso il workshop “Relazioni Pericolose: Acquisizioni e Innovazione nel Settore Farmaceutico”, un evento che ha acceso il dibattito sulle killer acquisitions, ovvero quelle operazioni di acquisizione strategica che possono frenare l’innovazione nel settore farmaceutico.

Read more

Killing Me Softly: Pharma Acquisitions and Competitive Harm

We are pleased to share our latest Lear Competition Note, “Killing Me Softly: Pharma Acquisitions and Competitive Harm,” based on the report we prepared for the European Commission on the phenomenon of killer acquisitions in the pharmaceutical sector.

Read more

The ICA clears Iren of excessive pricing allegations

Lear – together with law firms Cleary Gottlieb and Grimaldi Alliance – has successfully assisted the Iren group in the context of an investigation by the Italian Competition Authority (“ICA”) into an alleged abuse of dominance in the district heating sector.
The investigation sought to ascertain whether price rises for the district heating service in the cities of Parma and Piacenza over the period 2021-2023 represented an instance of excessive pricing. The final decision issued by the ICA acknowledges that the prices charged by Iren were not excessive and no infringement occurred. Read more

Workshop – Relazioni Pericolose: Acquisizioni e innovazione nel settore farmaceutico

📢 Siamo entusiasti di annunciare il nostro prossimo evento: il workshop “Relazioni Pericolose: Acquisizioni e innovazione nel settore farmaceutico”, che si terrà a Milano il 29 gennaio 2025.

Il fenomeno delle killer acquisition – ovvero, le transazioni che hanno come obiettivo o effetto l’eliminazione di innovazioni potenzialmente concorrenti – è un tema che suscita crescente attenzione, soprattutto nel settore farmaceutico. Ma quanto è realmente diffuso questo fenomeno, e come possiamo identificarlo? Quali sono gli strumenti che le autorità della concorrenza possono utilizzare per esaminarle? Read more

Study on Killer Acquisitions in the Pharma Sector

We are thrilled to announce that our report on ‘killer acquisitions’ in the pharmaceutical sector has been published by the European Commission.

Read more